Olympia Pharmacy: What It Is and Who Uses It

Olympia is one of the older names in this market and one of the more confusing ones, because a single brand covers two separately regulated businesses whose names differ by three letters. Olympia Pharmaceuticals is the FDA-registered outsourcing facility. Olympia Pharmacy is the affiliated state-licensed compounding pharmacy. Which one made your vial decides which rulebook it was made under. Checked August 29, 2026.

Two entities, one brand

The company's own homepage sets it out: "Olympia Pharmaceuticals is a 503B FDA-registered outsourcing facility," and "Our affiliated 503A pharmacy, Olympia Pharmacy, extends this service"¹. Its footer carries two phone numbers against two Orlando addresses — a Conroy Road line marked 503B, and an L B McLeod Road line marked 503A³. The about page dates the business to "2009 – Olympia Compounding Pharmacy is founded," describes the company as "family-owned by two generations of pharmacists," and is signed by "Dr. Mark Mikhael, PharmD, Chief Executive Officer, Olympia Pharmaceuticals"³.

The split is not cosmetic. Olympia explains its own division of labor with unusual precision: "Non-sterile creams, capsules and tablets are compounded at our 503A facility. Only a small handful of sterile injectables are compounded at the 503A pharmacy." And on what each side may legally sell: "503A facilities can only dispense patient prescriptions. Large batch sizes and compounded medications for office use are not authorized from a 503A pharmacy"². The 503B side, the company says, is "required to meet more stringent cGMP guidelines than our 503A facility"².

That tracks the federal rule. The FDA describes outsourcing facilities as "a category of compounders established in 2013 by the Drug Quality and Security Act" that "are inspected by FDA according to a risk-based schedule and are subject to increased quality standards," and notes that drugs compounded in a state-licensed pharmacy under section 503A are not subject to current good manufacturing practice requirements⁶.

What FDA's register records

FDA publishes a weekly table of every facility registered as an outsourcing facility under section 503B. On the version read August 29, 2026 it carried 98 facilities, and "Olympia Pharmaceuticals, Orlando, FL" was one of them — initially registered March 10, 2014, most recently registered November 20, 2025, last inspected August 8, 2025, with a Form FDA 483 recorded and an "Action Based on Last Inspection" of "Open"⁵.

Both of those last two terms are defined on the page itself, and both are narrower than they sound. A Form FDA 483 "is issued when investigators observe any significant objectionable conditions. It does not constitute a final agency determination of whether any condition is in violation of the FD&C Act or any relevant regulations." And "'Open' means FDA has not determined whether further action will be taken"⁵. So the honest reading is: this facility was inspected last August, the investigators wrote observations, and the file is not closed. That is more than most compounding pharmacies disclose about themselves, because most are not on this list at all.

We also read FDA's warning-letter index in full that day — 3,664 letters, of which 59 carry a compounding subject — and fetched all 59 bodies. None is addressed to Olympia Pharmaceuticals or Olympia Pharmacy. The same pass returns three letters addressed to Empower, so the search was working when it found nothing here. One caution: FDA addresses letters to legal entities at street addresses, so an absence keyed on a name is weaker evidence than a hit, and FDA's own table notes that it "does not include State Board of Pharmacy actions, if any"⁵.

What Olympia says it compounds

The catalog is broad and mostly non-GLP-1: the homepage and product directory list NAD+ injections, hormone preparations, IV therapy, dermatology compounds and injectable nutrients¹. Weight management is a listed category, and the page devoted to it discusses the drug class in general terms — "GLP-1 agonists are an important development in weight management, particularly for those with type 2 diabetes. They work by mimicking a natural hormone (glucagon-like peptide-1), helping regulate appetite and promote a feeling of fullness"⁴.

One detail is worth reporting precisely, and precisely bounded. On August 29, 2026, that weight-management page linked exactly one GLP-1 product page — liraglutide injection — and its HTML contained no occurrence of the words semaglutide or tirzepatide⁴. That is a statement about one page on one day. It is not a claim about the whole catalog, because the site's own product search is client-side and returns nothing to an ordinary fetch, including for products the site plainly carries. If you want to know whether Olympia is compounding a specific molecule for a specific seller today, ask the seller and ask Olympia. The footer of the same page carries the disclosure that covers all of it: "Compounded products are not approved by the FDA. This means the FDA does not review these drugs for safety, efficacy, or quality before they reach patients"⁴.

Who dispenses through Olympia

Three of the 507 companies tracked here name Olympia in their own public disclosures, computed from our record on August 29, 2026: DoctorAdam, which names Olympia Pharmaceuticals of Orlando alongside a second pharmacy; Tonik Wellness, which names two 503A partners; and Risen Labs, which names Olympia Pharmacy as a 503A compounding pharmacy and discloses its own legal entity. Companies that publish no pharmacy name at all cannot appear in a count like this, so three is the number that discloses, not the number that uses.

Notice that two of the three name the 503A side. Given Olympia's own statement that only a small handful of sterile injectables are compounded at the 503A pharmacy, "Olympia" on an invoice is worth one follow-up question: which of the two facilities, and for which product.

Checking this yourself

Ask for the pharmacy name in writing. Search FDA's registered outsourcing facilities table for it — if the name is there, you get a registration date, the last inspection date and whether a Form 483 was issued, all from the federal register rather than from marketing. If it is not there, the pharmacy is almost certainly 503A, and the right lookup is your own state board of pharmacy's nonresident pharmacy license search. Then search FDA's warning-letter database on the legal entity name, not the brand.

The other pharmacies named most often here have their own pages: Empower, Hallandale and Red Rock. The rules behind the categories are in is compounded GLP-1 legit and safe, the operator checks are in how to tell if a GLP-1 provider is legit, coverage by state is at GLP-1 telehealth by state, and the brand-versus-compounded decision is at compounded vs brand-name GLP-1. Our sources are indexed in the research library.